Rifaximin monotherapy was effective in patients with newly diagnosed Crohn's disease

被引：0
|
作者：
Shafran, Ira [1 ]
Burgunder, P. [1 ]
机构：
[1] Shafran Gastroenterol Ctr, Winter Pk, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2008年 / 103卷
关键词：
D O I：
10.14309/00000434-200809001-00611
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
611
引用
收藏
页码：S237 / S237
页数：1
相关论文
共 50 条
  • [31] Experience of Disease Acceptance in Chinese Patients with Newly Diagnosed Crohn's Disease: A Descriptive Qualitative Study
    Wang, Ying
    Liu, Jinghan
    Zhou, Yunxian
    PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 2523 - 2534
  • [32] CONVENTIONAL BIOMARKERS IN NEWLY DIAGNOSED CROHN'S DISEASE PATIENTS MAY PREDICT EARLY DISEASE PROGRESSION
    Yanai, Henit A.
    Goren, Idan
    Godny, Lihi
    Ben-Shachar, Shay
    Maharshak, Nitsan
    Ron, Yulia
    Yadgar, Karin
    Zonenesain, Keren
    Ziv-Baran, Tomer
    Dotan, Iris
    GASTROENTEROLOGY, 2018, 154 (06) : S633 - S633
  • [33] Conventional biomarkers in newly diagnosed Crohn's disease patients may predict early disease progression
    Yanai, H.
    Goren, I.
    Godny, L.
    Ben-Shachar, S.
    Maharshak, N.
    Ron, Y.
    Yadgar, K.
    Zonenesain, K.
    Ziv-Baran, T.
    Dotan, I.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S280 - S280
  • [34] Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn’s disease
    Jessika Barendregt
    Myrthe de Jong
    Jeoffrey J. Haans
    Bart van Hoek
    James Hardwick
    Roeland Veenendaal
    Andrea van der Meulen
    Nidhi Srivastava
    Rogier Stuyt
    Jeroen Maljaars
    International Journal of Colorectal Disease, 2017, 32 : 459 - 467
  • [35] Liver test abnormalities predict complicated disease behaviour in patients with newly diagnosed Crohn's disease
    Barendregt, Jessika
    de Jong, Myrthe
    Haans, Jeoffrey J.
    van Hoek, Bart
    Hardwick, James
    Veenendaal, Roeland
    van der Meulen, Andrea
    Srivastava, Nidhi
    Stuyt, Rogier
    Maljaars, Jeroen
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2017, 32 (04) : 459 - 467
  • [36] Course and Treatment of Perianal Disease in Children Newly Diagnosed with Crohn's Disease
    Keljo, David J.
    Markowitz, James
    Langton, Christine
    Lerer, Trudy
    Bousvaros, Athos
    Carvalho, Ryan
    Crandall, Wallace
    Evans, Jonathan
    Griffiths, Anne
    Kay, Marsha
    Kugathasan, Subra
    LeLeiko, Neal
    Mack, David
    Mamula, Petar
    Moyer, M. Susan
    Oliva-Hemker, Maria
    Otley, Anthony
    Pfefferkorn, Marian
    Rosh, Joel
    Hyams, Jeffrey S.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (03) : 383 - 387
  • [37] Prospective Evaluation of the Prediction Score for a Mild Course of Crohn's Disease (PreMiCC) in Newly Diagnosed Patients With Crohn's Disease: The PROGNOS Study
    Kruis, Wolfgang
    Bokemeyer, Bernd
    Jessen, Petra
    Hoesl, Mark
    Mross, Michael
    Morgenstern, Julia
    Reimers, Birgitta
    Mueller-Grage, Nike
    Leifeld, Ludger
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [38] Improvement of psychological status after infliximab treatment in patients with newly diagnosed Crohn's disease
    Zhang, Maochen
    Zhang, Tianyu
    Hong, Liwen
    Zhang, Chen
    Zhou, Jie
    Fan, Rong
    Wang, Lei
    Wang, Zhengting
    Xu, Bin
    Zhong, Jie
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 879 - 885
  • [39] Patients with newly diagnosed fistulizing perianal Crohn's disease have a distinct microbial signature
    Goren, I.
    Ian, W.
    Reshef, L.
    Fischler, T. Sharar
    Pauker, M.
    Silverman, J.
    Dotan, I.
    Yanai, H.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S602 - S602
  • [40] The impact of different treatment strategies in newly diagnosed patients with Crohn's Disease: a multicentre study
    Reves, J.
    Morao, B.
    Montanaro, G.
    Sciberras, N.
    Bravo, A. C.
    Gloria, L.
    Ellul, P.
    Torres, J.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 942 - 943
12345